Yu Yanlan, Gao Fengbin, He Qian, Li Gonghui, Ding Guoqing
Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
Mol Ther Nucleic Acids. 2020 Mar 6;19:751-758. doi: 10.1016/j.omtn.2019.11.021. Epub 2019 Nov 27.
UCA1 (urothelial carcinoma associated 1) is a long non-coding RNA (lncRNA) that was found overexpressed in various human cancers including prostate cancer (PCa). However, the aspect of UCA1-miRNA-mRNA interaction in PCa remains unclear. In this study, we confirmed the role of UCA1 in PCa and found that UCA1 downregulation inhibited cell proliferation of PCa cells. Then we demonstrated that repressed UCA1 promoted the microRNA-143 (miR-143) expression and miR-143 could bind to the predicted binding site of UCA1. We then proved the anti-tumor role of miR-143 in PCa. Furthermore, we found that miR-143 displays its role in PCa via modulating the MYO6 expression. In summary, our study demonstrated that UCA1 exerts oncogenes activity in PCa, acting mechanistically by upregulating MYO6 expression through "sponging" miR-143.
UCA1(尿路上皮癌相关1)是一种长链非编码RNA(lncRNA),在包括前列腺癌(PCa)在内的多种人类癌症中被发现过表达。然而,UCA1在前列腺癌中与微小RNA(miRNA)-信使核糖核酸(mRNA)相互作用的方面仍不清楚。在本研究中,我们证实了UCA1在前列腺癌中的作用,发现UCA1下调抑制了前列腺癌细胞的增殖。然后我们证明,受抑制的UCA1可促进微小RNA-143(miR-143)的表达,且miR-143可与UCA1的预测结合位点结合。我们随后证明了miR-143在前列腺癌中的抗肿瘤作用。此外,我们发现miR-143通过调节肌球蛋白VI(MYO6)的表达在前列腺癌中发挥作用。总之,我们的研究表明,UCA1在前列腺癌中发挥癌基因活性,其作用机制是通过“吸附”miR-143上调MYO6的表达。